Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Rashmi Kumari

Are These 3 Pharma Stocks a Buy or Hold Opportunity for December?

The pharmaceutical industry is poised for long-term growth due to the growing global population, aging demographics, technological advancements, and innovative drug development. However, I think it could be wise to wait for a better entry point in Procaps Group S.A. (PROC), Voyager Therapeutics, Inc. (VYGR) and Organon & Co. (OGN).

Before delving deeper into their fundamentals, let’s discuss what’s happening in the pharma industry.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.